PHAR

Pharming Group N.V.

Healthcare›Biotechnology|NASDAQ Global Market|NL

Price

$16.62

Market Cap

$1.10B

Beta

0.16

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+26.54%

EPS Growth (YoY)+122.69%

Revenue CAGR 3Y+22.78%

P/E Ratio0.0

PEG Ratio—

FCF Yield+4.41%

Debt / Equity0.42

Interest Coverage0.0x

No credit card required

Already have an account? Sign in to view the full analysis for PHAR.